ANI Pharmaceuticals | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.86B 306M 2024-12
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Knight Therapeutics CAD 25.48M 119K 2024-09
Novartis USD 3.5B 368M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Sun Pharmaceuticals INR 25.52B 745.8M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12



ANI Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2025.